Included in the UK Royal College of Surgeons national cosmetic surgery quality improvement initiative to measure outcomes for blepharoplasty, rhinoplasty, and rhytidectomy.
Increasingly used in clinical practice to measure outcomes from the patient perspective.
Basic Scale Structure
The FACE-Q is designed to provide clinicians and researchers with the ability to customize the questionnaire to suit their needs. The FACE-Q Aesthetics module measures 3 overarching domains: Facial Appearance, Quality of Life and Adverse Effects. Each domain includes multiple independently functioning scales. The conceptual framework shown below was developed from 85 qualitative interviews with patients having a broad range of surgical and nonsurgical facial aesthetic treatments, careful examination of the research literature and engagement with 26 healthcare professionals working with facial rejuvenation patients. .
The FACE-Q Aesthetics module contains a comprehensive set of 23 appearance scales. These scales include 16 scales that measure the appearance of the face overall and of specific facial features and areas and 7 scales that measure the appearance of facial lines overall and for specific areas of the face. A new scale for temple appearance is being developed.
The FACE-Q Aesthetics module includes a set of 6 checklists that can be used to measure adverse effects associated with aesthetic treatments. These checklists cover the cheeks, lower face and neck area, eyes, forehead, eyebrows and scalp area, lips, nose, and skin.
QUALITY OF LIFE
The FACE-Q Aesthetic module includes a set of 10 scales that measure aspects of quality of life. These scales include an aging appraisal scale that measures perception of appearance in the context of facial aging and an age visual analog scale that measures perceived age in comparison to actual age. For screening purposes, this FACE-Q module has a scale that measures expectations on how appearance and quality of life might change after treatment and an appearance-related psychosocial distress scale. There are 2 scales relevant to the early recovery period that measure early symptoms and early life impact of treatment. This domain also includes psychological and social function scales and scales to measure satisfaction with the decision to have treatment and the overall result of treatment.